These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9972140)

  • 21. Host modulation with tetracyclines and their chemically modified analogues.
    Golub LM; Suomalainen K; Sorsa T
    Curr Opin Dent; 1992 Mar; 2():80-90. PubMed ID: 1325849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of tetracyclines on bones: an ambiguous question needs to be clarified.
    Cheng W; Yue Y; Fan W; Hu Y; Wang X; Pan X; Zhou X; Qin L; Zhang P
    Pharmazie; 2012 May; 67(5):457-9. PubMed ID: 22764582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix metalloproteinase inhibitor properties of tetracyclines: therapeutic potential in cardiovascular diseases.
    Castro MM; Kandasamy AD; Youssef N; Schulz R
    Pharmacol Res; 2011 Dec; 64(6):551-60. PubMed ID: 21689755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An update on tetracyclines.
    Shlaes DM
    Curr Opin Investig Drugs; 2006 Feb; 7(2):167-71. PubMed ID: 16499287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-antimicrobial and antimicrobial tetracyclines inhibit IL-6 expression in murine osteoblasts.
    Kirkwood KL; Golub LM; Bradford PG
    Ann N Y Acad Sci; 1999 Jun; 878():667-70. PubMed ID: 10415803
    [No Abstract]   [Full Text] [Related]  

  • 26. Tetracyclines (TCs) inhibit matrix metalloproteinases (MMPs): in vivo effects in arthritic and diabetic rats and new in vitro studies.
    Golub L; Greenwald R; Ramamurthy N; Zucker S; Ramsammy L; McNamara T
    Matrix Suppl; 1992; 1():315-6. PubMed ID: 1480048
    [No Abstract]   [Full Text] [Related]  

  • 27. Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature.
    Griffin MO; Fricovsky E; Ceballos G; Villarreal F
    Am J Physiol Cell Physiol; 2010 Sep; 299(3):C539-48. PubMed ID: 20592239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine-processing enzymes. Stopping the cuts.
    Dinarello CA; Margolis NH
    Curr Biol; 1995 Jun; 5(6):587-90. PubMed ID: 7552162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Amadacyclin - a new tetracycline antibiotic in the pipeline].
    Schmitz J; Holzgrabe U
    Pharm Unserer Zeit; 2010 Mar; 39(2):94-5. PubMed ID: 20196060
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemically modified tetracyclines act through multiple mechanisms directly on osteoclast precursors.
    Holmes SG; Still K; Buttle DJ; Bishop NJ; Grabowski PS
    Bone; 2004 Aug; 35(2):471-8. PubMed ID: 15268899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial and non-antimicrobial tetracyclines in human cancer trials.
    Richards C; Pantanowitz L; Dezube BJ
    Pharmacol Res; 2011 Feb; 63(2):151-6. PubMed ID: 20951804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-inflammatory activity of tetracyclines.
    Webster G; Del Rosso JQ
    Dermatol Clin; 2007 Apr; 25(2):133-5, v. PubMed ID: 17430750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AE 941--Neovastat.
    Drugs R D; 1999 Feb; 1(2):135-6. PubMed ID: 10566006
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemically modified non-antimicrobial tetracyclines inhibit activity of phospholipases A2.
    Pruzanski W; Stefanski E; Vadas P; McNamara TF; Ramamurthy N; Golub LM
    J Rheumatol; 1998 Sep; 25(9):1807-12. PubMed ID: 9733464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional sites of chemically modified tetracyclines: inhibition of the oxidative activation of human neutrophil and chicken osteoclast pro-matrix metalloproteinases.
    Sorsa T; Ramamurthy NS; Vernillo AT; Zhang X; Konttinen YT; Rifkin BR; Golub LM
    J Rheumatol; 1998 May; 25(5):975-82. PubMed ID: 9598901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro inhibition of aggrecanase activity by tetracyclines and proteoglycan loss from osteoarthritic human articular cartilage.
    Steinmeyer J; Kordelle J; Stürz H
    J Orthop Res; 2010 Jun; 28(6):828-33. PubMed ID: 20069635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remodeling MMPIs.
    Hodgson J
    Biotechnology (N Y); 1995 Jun; 13(6):554-7. PubMed ID: 9634794
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tetracyclines, sulfonamides, and metronidazole].
    Vicente D; Pérez-Trallero E
    Enferm Infecc Microbiol Clin; 2010 Feb; 28(2):122-30. PubMed ID: 20097452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetracyclines: nonantibiotic properties and their clinical implications.
    Sapadin AN; Fleischmajer R
    J Am Acad Dermatol; 2006 Feb; 54(2):258-65. PubMed ID: 16443056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supportive pharmacotherapy for patients with acute respiratory distress syndrome.
    Krafft P; Fridrich P; Hammerle AF; Steltzer H
    Acta Anaesthesiol Scand Suppl; 1996; 109():65-9. PubMed ID: 8901950
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.